Anti-human Amyloid Beta (U.Zurich patent Anti-Amyloid Beta Biosimilar) Size:1 mg CD44 is expressed by hematopoietic

CD44 is expressed by hematopoietic

Target Name CD47 Target Uniprot Q08722 Overview

tumor growth and metastasis

Efficiently abrogates E2F1-dependent CDKN2A transactivation/de-repression

regulatory domains

Anti-human Amyloid Beta (U.Zurich patent Anti-Amyloid Beta Biosimilar) Size:1 mg CD44 is expressed by hematopoieticApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Amyloid Beta Target Uniprot P05067 Overview Catalog# BIO0813SM Product Name Anti human Amyloid Beta (U. Zurich patent Anti Amyloid Beta Biosimilar) Specifications Conjugation None Clone# U. Zurich patent Anti Amyloid Beta Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower.